Cystic fibrosis patients suffer from polymicrobial lung infections. The main agents of clinical interest are Staphylococcus aureus and Pseudomonas aeruginosa. These two bacteria co-infect up to 40% of patients and are able, under these conditions, to interact in two different ways. P. aeruginosa strains of early infection are in competition with S. aureus, while strains of chronic infection can coexist. The latter state remains little described but could favour the persistence of the two pathogens in the lungs of the patients. We therefore seek to understand the mechanism of this coexistence state by studying clinical strains. We first studied the impact of coexistence on P. aeruginosa physiology using a transcriptomic approach and highlig...